Neuphoria Therapeutics (NEUP) Receivables - Net (2020 - 2025)
Historic Receivables - Net for Neuphoria Therapeutics (NEUP) over the last 6 years, with Q4 2025 value amounting to -$1.1 million.
- Neuphoria Therapeutics' Receivables - Net fell 318753.97% to -$1.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$1.1 million, marking a year-over-year decrease of 318753.97%. This contributed to the annual value of $11948.0 for FY2025, which is N/A changed from last year.
- As of Q4 2025, Neuphoria Therapeutics' Receivables - Net stood at -$1.1 million, which was down 318753.97% from $1758.0 recorded in Q3 2025.
- Neuphoria Therapeutics' Receivables - Net's 5-year high stood at $429272.6 during Q2 2023, with a 5-year trough of -$1.1 million in Q4 2025.
- Its 5-year average for Receivables - Net is -$46103.2, with a median of $24592.0 in 2025.
- As far as peak fluctuations go, Neuphoria Therapeutics' Receivables - Net skyrocketed by 83119.66% in 2023, and later tumbled by 318753.97% in 2025.
- Over the past 5 years, Neuphoria Therapeutics' Receivables - Net (Quarter) stood at $17841.0 in 2021, then skyrocketed by 158.39% to $46099.0 in 2022, then soared by 831.2% to $429272.6 in 2023, then plummeted by 91.72% to $35561.0 in 2024, then plummeted by 3187.54% to -$1.1 million in 2025.
- Its last three reported values are -$1.1 million in Q4 2025, $1758.0 for Q3 2025, and $11948.0 during Q2 2025.